Biotechnology Stocks II Performance Guide: Heron Therapeutics, Inc. (HRTX)
HRTX has no dividends.
Table and Chart of HRTX Performance
See what a $1,000 investment in HRTX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| HRTX Returns | |
|---|---|
| Start Date | Jul-31-2014 |
| Start Price | $8.79 |
| End Date | Jul-26-2024 |
| End Price | $3.05 |
| # Prices | 121 |
| Min Date | Oct-31-2023 |
| Min Price | $0.64 |
| Max Date | Jun-29-2018 |
| Max Price | $38.85 |
| Total Return | -65.30% |
| Annualized Return | -9.97% |
| Current Value of $1,000 Purchase | $347 |
| Number Returns | 7,260 |
| Average Return | -21.99% |
| Number Profitable Returns | 2,079 |
| Percent Profitable Returns | 28.64% |
| Number Unprofitable Returns | 5,181 |
| Percent Unprofitable Returns | 71.36% |
| Profitable to Unprofitable Returns Ratio | 0.40 |
| HRTX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $467,024,000 |
| Beta | 1.806 | Price to Sales | 3.44 |
| Earnings per Share | $-0.5500 |
| PE Ratio | None |
| PE to Growth Ratio | -0.18 |
| Price to Book | 12.6 |
| PRICE DATA | |
| 52 Week High | $3.93 |
| 52 Week Low | $0.5 |
| Analyst Target Price | $6.75 |
| 50-Day Moving Average | $3.334 |
| 200-Day Moving Average | $2.342 |
| FINANCIAL DATA | |
| Revenue per Share | $0.904 |
| Revenue | $132,099,000 |
| Profit Margin | -61.3% |
| Return on Equity | -2409% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
HRTX Compare Returns with S&P 500
HRTX Trendline Chart
HRTX Moving Average Chart
HRTX Stock Return Map - See Patterns of Gains and Losses
HRTX Stock Returns/Purchase Dates